跳到主要內容

臺灣博碩士論文加值系統

(44.200.194.255) 您好!臺灣時間:2024/07/24 05:35
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:AVWEROSUOGHENE ONOBRAKPEYA
研究生(外文):AVWEROSUOGHENE ONOBRAKPEYA
論文名稱:奈及利亞Covid-19 疫苗猶豫的決定因素
論文名稱(外文):Determinants Of Covid-19 Vaccine Hesitancy In Nigeria From A Qualitative Perspective
指導教授:許良因許良因引用關係
指導教授(外文):HSU, LIANG-YIN
口試委員:盧鴻毅鄭嫥嫥
口試委員(外文):LU, HUNG-YICHENG, CHUAN-CHUAN
口試日期:2024-01-05
學位類別:碩士
校院名稱:慈濟大學
系所名稱:公共衛生學系碩士班
學門:醫藥衛生學門
學類:公共衛生學類
論文種類:學術論文
論文出版年:2024
畢業學年度:112
語文別:英文
論文頁數:111
外文關鍵詞:COVID-19VACCINE HESITANCYTRUSTAUTHORITYDISTRUSTQUALITATIVEKNOWLEDGE GROWTHDOUBTPERCEPTIONSDETERMINANTSINTERVIEWSNIGERIAVACCINATION PATHWAYS
相關次數:
  • 被引用被引用:0
  • 點閱點閱:23
  • 評分評分:
  • 下載下載:3
  • 收藏至我的研究室書目清單書目收藏:0
The Covid-19 vaccine is intended to provide acquired immunity against Covid-19. In Nigeria, as of December 2022, the number of fully vaccinated was 23.7% of the entire 216 million population. Vaccine hesitancy is not a novel phenomenon and the Covid-19 vaccine is facing this public health issue that is threatening public health measures. Previous research has only scratched the surface regarding this topic, as they presented the data, and not what drives the data.

This research aimed to understand the determinants of Covid-19 vaccine hesitancy in Nigeria, as well as understand the decision-making process behind the choice to vaccinate or not.

This research employed a qualitative research methodology, utilizing semi-structured interviews which were carried out via WhatsApp. Eighteen participants were selected using a purposive sampling procedure.

In this research, the determinants of Covid-19 vaccine hesitancy identified were Doubt-based determinants: (1) Doubt in the vaccine, manufacturers and available vaccine knowledge, (2) Distrust and dissatisfaction in the government, and (3) Doubt in Covid-19’s existence, (4) Perceptions and beliefs-based determinants and (5) Situational determinants.

For the decision-making process, three pathways were identified: The Hesitant -
Vaccinated Pathway, The Hesitant - Unvaccinated Pathway and The Willing - Hesitant - Unvaccinated Pathway. Family influence was found to not have a strong effect in decision making.

It is very crucial to understand that these determinants were not limited to socioeconomic status, or education level, as this in-depth research has shown that vaccine hesitancy goes beyond these demographic parameters.
ACKNOWLEDGEMENT
ABSTRACT
Table of Contents
List of Tables
List of Figures

CHAPTER ONE
INTRODUCTION
1.1 Background
1.2 Aims of the Study
1.3 Objectives of the Study
1.4 Justification of the Study

CHAPTER TWO
LITERATURE REVIEW
2.1 Background of Covid-19
2.2 Covid-19 Vaccination
2.3 Vaccine Hesitancy
2.4 Covid-19 Vaccine Hesitancy
2.5 Summary of Literature Review
2.6 Grounded Theory

CHAPTER THREE
MATERIALS AND METHODS
3.1 Study Population
3.2 Data Collection
3.3 Ethical Approval
3.4 Data Analysis
3.5 Ethical Considerations and Validation
3.5.1 Confidentiality and privacy
3.5.2 Establishment of honest and open interactions
3.5.3 Misrepresentation

CHAPTER FOUR
RESULTS
4.1 Characteristics of Participants
4.2 Reasons for Refusal to Vaccinate
4.2.1 Doubt-associated determinants
4.2.2 Perceptions and Beliefs
4 2 3 Situational Determinants
4.3 Reasons for Shift
4.3.1 Authority
4.3.2 Knowledge Growth and Self-Preservation
4.3.3 Trust
4.3.4 Strong Ties
4.4 Rumors recounted by participants
4.5 Decision Making Process
4.5.1 The Hesitant - Vaccinated Pathway
4.5.2 The Hesitant - Unvaccinated Pathway
4.5.3 The Willing - Hesitant - Unvaccinated Pathway

CHAPTER FIVE
DISCUSSION
5.1 Determinants of Vaccine Hesitancy
5.2 Reasons for Shift
5.3 Decision Making process
5.4 Family Influence
5.5 Strengths and Limitations

CHAPTER SIX
CONCLUSION

REFERENCES

APPENDIX I
INTERVIEW GUIDE

APPENDIX II
STATEMENT OF SUBJECT CONSENT

APPENDIX III
APPROVED CALL FOR PARTICIPANTS

APPENDIX IV
ETHICAL APPROVAL FROM HUALIEN TZU CHI HOSPITAL ETHICAL REVIEW COMMITTEE

APPENDIX V
ETHICAL APPROVAL FROM NIGERIA NATIONAL HEALTH RESEARCH ETHICS COMMITTEE

List of Tables
Table 1 Some Vaccines Approved for use and their Approaches
Table 2 Summary of Some determinants of Covid-19 vaccine hesitancy
Table 3 Qualitative Studies in Nigeria
Table 4: Demographic Characteristics of Participants
Table 5 Distribution of participants and their demographic information
Table 6: Rumors recounted by participants

List of Figures
Figure 1 Indicative timelines for COVID-19 vaccines compared with standard vaccines
Figure 2 Determinants of Covid-19 Vaccine Hesitancy
Figure 3 Hesitant - Vaccinated Pathway
Figure 4 Hesitant - Unvaccinated Pathway
Figure 5 Willing - Hesitant - Unvaccinated Pathway
1.
Coronavirus disease (COVID-19) pandemic. World Health Organization. Accessed
January 2, 2023. https://www.who.int/europe/emergencies/situations/covid-19
2.
First Case of Corona Virus Disease Confirmed in Nigeria. Nigeria Centre for Disease
Control and Prevention. Published February 28, 2020. Accessed January 2, 2023.
https://ncdc.gov.ng/news/227/first-case-of-corona-virus-disease-confirmed-in-nigeria
3.
COVID-19 Vaccination. Africa CDC. Accessed January 2, 2023.
https://africacdc.org/covid-19-vaccination/
4.
Nigeria receives four million Covid vaccine doses from the US. Africanews. Published
August 1, 2021. Accessed January 2, 2023. https://www.africanews.com/2021/08/01/nigeria-
receives-four-million-covid-vacine-doses-from-the-us/
5.
Adebowale-Tambe N. Nigeria receives 100,000 doses of COVID-19 vaccine from
India. Premium Times. Published April 6, 2021. Accessed January 2, 2023.
https://www.premiumtimesng.com/news/top-news/453600-nigeria-receives-100000-doses-of-
covid-19-vaccine-from-india.html?tztc=1
6.
Adebowale-Tambe N. Nigeria receives 501,600 doses of AstraZeneca vaccines from
France. Premium Times. Published October 8, 2021. Accessed January 2, 2023.
https://www.premiumtimesng.com/news/top-news/488973-nigeria-receives-501600-doses-of-
astrazeneca-vaccines-from-france.html
7.
Usigbe L. Nigeria: COVID-19 vaccine rollout kicks off in Africa’s most populous
country. Africa Renewal. Published April 6, 2021. Accessed January 2, 2023.
https://www.un.org/africarenewal/magazine/april-2021/nigeria-covid-19-vaccine-rollout-kicks-
africas-most-populous-country
8.
Basta N, Moodle E, On behalf of the VIPER (Vaccines, Infectious disease Prevention,
and Epidemiology Research) Group COVID-19 Vaccine Development and Approvals Tracker
Team. Nigeria – 7 Vaccines Approved for Use in Nigeria. COVID-19 Vaccine Development
and Approvals Tracker. Published 2020. Accessed January 2, 2023.
https://covid19.trackvaccines.org/country/nigeria/
9.
World Population Dashboard -Nigeria. United Nations Population Fund. Accessed
January 2, 2023. https://www.unfpa.org/data/world-population/NG
10.
Ten health issues WHO will tackle this year. World Health Organization. Accessed
January 2, 2023. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
11.
National Planning Commission. NIGERIA: National Economic Empowerment and
Development Strategy (NEEDS). Published online March 2004.
file:///C:/Users/Avwerosuo/Downloads/National-Economic-Empowerment-and-Development-
Strategy-NEEDS.pdf
12.
Aw J, Seng JJB, Seah SSY, Low LL. COVID-19 Vaccine Hesitancy—A Scoping
Review of Literature in High-Income Countries. Vaccines (Basel). 2021;9(8):900.
doi:10.3390/vaccines9080900
13.
Ojewale L, Mukumbang F. COVID-19 vaccine hesitancy among Nigerians living with
non- communicable diseases: a qualitative study. BMJ Open. 2023;13:65901.
doi:10.1136/bmjopen-2022-065901
14.
COVID-19 cases | WHO COVID-19 dashboard. World Health Organization. Accessed
January 2, 2023. https://data.who.int/dashboards/covid19/cases
15.
Q&A: How is COVID-19 transmitted? World Health Organization. Published July 14,
2022. Accessed November 21, 2022. https://www.who.int/vietnam/news/detail/14-07-2020-q-
a-how-is-covid-19-transmitted
9016.
Interim Clinical Considerations for COVID-19 Treatment in Outpatients. Centers for
Disease Control and Prevention. Accessed January 2, 2023.
https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/outpatient-treatment-
overview.html
17.
Coronavirus disease (COVID-19): Vaccines and vaccine safety. World Health
Organization. Published May 17, 2022. Accessed January 2, 2023. https://www.who.int/news-
room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines
18.
COVID-19 vaccines: development, evaluation, approval and monitoring. European
Medicines Agency. Accessed November 21, 2022. https://www.ema.europa.eu/en/human-
regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-public-
health-emergency-international-concern-2020-23/covid-19-vaccines-development-evaluation-
approval-and-monitoring
19.
Approval of vaccines in the European Union. European Centre for Disease Prevention
and Control (ECDC). Published September 11, 2020. Accessed November 21, 2022.
https://vaccination-info.europa.eu/en/vaccine-facts/approval-vaccines-european-union
20.
COVID-19 vaccine tracker and landscape. World Health Organization.
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
21.
The different types of COVID-19 vaccines. World Health Organization. Published
January 12, 2021. Accessed November 21, 2022. https://www.who.int/news-room/feature-
stories/detail/the-race-for-a-covid-19-vaccine-explained
22.
Basta N, Moodle E, On behalf of the VIPER (Vaccines, Infectious disease Prevention,
and Epidemiology Research) Group COVID-19 Vaccine Development and Approvals Tracker
Team. Approved Vaccines – COVID19 Vaccine Tracker. COVID-19 Vaccine Development
and Approvals Tracker. Published 2020. Accessed January 2, 2023.
https://covid19.trackvaccines.org/vaccines/approved/
23.
Pennington M. History of Vaccine Hesitancy. Charles River. Published July 29, 2021.
Accessed January 2, 2023. https://www.criver.com/eureka/history-vaccine-hesitancy
24.
MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy:
Definition, scope and determinants. Vaccine. 2015;33(34):4161-4164.
doi:10.1016/j.vaccine.2015.04.036
25.
Ten Great Public Health Achievements -- United States, 1900-1999. Centers for
Disease Control and Prevention. Published May 2, 2001. Accessed November 21, 2022.
https://www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm
26.
A Brief History of Vaccination. World Health Organization. Accessed November 21,
2022. https://www.who.int/news-room/spotlight/history-of-vaccination/a-brief-history-of-
vaccination
27.
Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine Hesitancy: Causes,
Consequences, and a Call to Action. American Journal of Preventive Medicine.
2015;49(6):S391-S398. doi:10.1016/j.amepre.2015.06.009
28.
Rosselli R, Martini M, Bragazzi NL. The old and the new: vaccine hesitancy in the era
of the Web 2.0. Challenges and opportunities. Journal of Preventive Medicine and Hygiene.
2016;57(1):E47.
29.
Public Understanding of Science: The Royal Society Reports. Science, Technology, &
Human Values. 1986;11(3):53-60.
30.
Goldenberg MJ. Vaccine Hesitancy: Public Trust, Expertise, and the War on Science.
University of Pittsburgh Press; 2021. doi:10.2307/j.ctv1ghv4s4
31.
Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an
overview. Hum Vaccin Immunother. 2013;9(8):1763-1773. doi:10.4161/hv.24657
9132.
Smallpox | CDC. Centers for Disease Control and Prevention. Published July 12, 2017.
Accessed November 21, 2022. https://www.cdc.gov/smallpox/index.html
33.
Vaccine-preventable Diseases. World Health Organization. Accessed November 21,
2022. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases
34.
STD Facts - Human papillomavirus (HPV). Centers for Disease Control and
Prevention. Published April 12, 2022. Accessed November 21, 2022.
https://www.cdc.gov/std/hpv/stdfact-hpv.htm
35.
HPV Vaccination: What Everyone Should Know. Centers for Disease Control and
Prevention. Published November 16, 2021. Accessed November 21, 2022.
https://www.cdc.gov/vaccines/vpd/hpv/public/index.html
36.
Tsui J, Martinez B, Shin MB, et al. Understanding medical mistrust and HPV vaccine
hesitancy among multiethnic parents in Los Angeles. J Behav Med. 2023;46(1-2):100-115.
doi:10.1007/s10865-022-00283-9
37.
Wei Z, Liu Y, Zhang L, et al. Stages of HPV Vaccine Hesitancy Among Guardians of
Female Secondary School Students in China. Journal of Adolescent Health. 2023;72(1):73-
79. doi:10.1016/j.jadohealth.2022.08.027
38.
Measles Vaccination. Centers for Disease Control and Prevention. Published January
26, 2021. Accessed November 21, 2022.
https://www.cdc.gov/vaccines/vpd/measles/index.html
39.
Sabahelzain MM, Moukhyer M, van den Borne B, Bosma H. Vaccine Hesitancy among
Parents and Its Association with the Uptake of Measles Vaccine in Urban Settings in
Khartoum State, Sudan. Vaccines (Basel). 2022;10(2):205. doi:10.3390/vaccines10020205
40.
Hepatitis B Vaccination. Centers for Disease Control and Prevention. Published March
30, 2022. Accessed November 21, 2022. https://www.cdc.gov/vaccines/vpd/hepb/index.html
41.
Afolabi IB, Aremu AB, Maidoki LA, Atulomah NO. Predictors of Hepatitis B Virus
Infection Vaccine Hesitancy Among Pregnant Women Attending Antenatal Care at Lubaga
Hospital, Kampala, Uganda. Int J Womens Health. 2022;14:1093-1104.
doi:10.2147/IJWH.S378000
42.
Deiana C, Geraci A, Mazzarella G, Sabatini F. Perceived risk and vaccine hesitancy:
Quasi‐experimental evidence from Italy. Health Econ. 2022;31(6):1266-1275.
doi:10.1002/hec.4506
43.
Lau BHP, Yuen SWH, Yue RPH, Grépin KA. Understanding the societal factors of
vaccine acceptance and hesitancy: evidence from Hong Kong. Public Health. 2022;207:39-
45. doi:10.1016/j.puhe.2022.03.013
44.
Mann S, Christini K, Chai Y, Chang CP, Hashibe M, Kepka D. Vaccine hesitancy and
COVID-19 immunization among rural young adults. Prev Med Rep. 2022;28:101845.
doi:10.1016/j.pmedr.2022.101845
45.
Schneider-Kamp A. COVID-19 Vaccine Hesitancy in Denmark and Russia: A
qualitative typology at the nexus of agency and health capital. SSM Qual Res Health.
2022;2:100116. doi:10.1016/j.ssmqr.2022.100116
46.
Hubach RD, Shannon B, Morgan KD, et al. COVID-19 vaccine hesitancy among rural
Oklahomans. Rural Remote Health. 2022;22(2):7128. doi:10.22605/RRH7128
47.
Modi BH, Pretorius D, Francis JM. A study on willingness to take the COVID-19
vaccine at a tertiary institution community in Johannesburg, South Africa. African Journal of
Primary Health Care & Family Medicine. 2022;14(1). doi:10.4102/phcfm.v14i1.3252
48.
Mubarak AS, Baabbad AS, Almalki NA, Alrbaiai GT, Alsufyani GA, Kabrah DK. Beliefs,
barriers, and acceptance associated with COVID-19 vaccination among Taif University
students in Saudi Arabia. J Family Med Prim Care. 2022;11(1):224-232.
doi:10.4103/jfmpc.jfmpc_1255_21
9249.
Gurenlian JR, Eldridge LA, Estrich CG, et al. COVID-19 Vaccine Intention and
Hesitancy of Dental Hygienists in the United States. J Dent Hyg. Published online 2022:5-16.
50.
Lee H, Noh EB, Kim JE, Oh J, Nam EW. Influencing factor of COVID-19 vaccination
trust and hesitancy in Wonju city, South Korea. PLoS One. 2022;17(11):e0277016.
doi:10.1371/journal.pone.0277016
51.
Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi
Arabia: A Web-Based National Survey. J Multidiscip Healthc. 2020;13:1657-1663.
doi:10.2147/JMDH.S276771
52.
Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. Parents’ and guardians’
views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England.
Vaccine. 2020;38(49):7789-7798. doi:10.1016/j.vaccine.2020.10.027
53.
Chandok RS, Madar P, Majeed A. A qualitative study of factors influencing COVID-19
vaccine hesitancy among South Asians in London. JRSM Open.
2022;13(10):20542704221123430. doi:10.1177/20542704221123430
54.
Osuagwu UL, Langsi R, Ovenseri-Ogbomo G, et al. Analysis of Perception, Reasons,
and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan
Africa: A Mixed-Method Approach. International Journal of Environmental Research and
Public Health. 2022;19(13). doi:10.3390/ijerph19137875
55.
Okafor UG, Isah A, Onuh JC, Mgbemena CB, Ubaka CM. Community acceptance and
willingness to pay for hypothetical COVID-19 vaccines in a developing country: a web-based
nationwide study in Nigeria. Pan Afr Med J. 2021;40:112.
doi:10.11604/pamj.2021.40.112.27780
56.
Kabagenyi A, Wasswa R, Nannyonga BK, et al. Factors Associated with COVID-19
Vaccine Hesitancy in Uganda: A Population-Based Cross-Sectional Survey. Int J Gen Med.
2022;15:6837-6847. doi:10.2147/IJGM.S372386
57.
Ilikannu SO, Uwadia OM, Enyi I, et al. COVID-19 Vaccine Hesitancy Among Patients
Attending the General Outpatient Clinic in a Tertiary Hospital in Southern Nigeria. Cureus.
2022;14(9):e29352. doi:10.7759/cureus.29352
58.
Agha S, Chine A, Lalika M, et al. Drivers of COVID-19 Vaccine Uptake amongst
Healthcare Workers (HCWs) in Nigeria. Vaccines (Basel). 2021;9(10):1162.
doi:10.3390/vaccines9101162
59.
Amuzie CI, Odini F, Kalu KU, et al. COVID-19 vaccine hesitancy among healthcare
workers and its socio-demographic determinants in Abia State, Southeastern Nigeria: a cross-
sectional study. Pan Afr Med J. 2021;40:10. doi:10.11604/pamj.2021.40.10.29816
60.
Ilesanmi O, Afolabi A, Falade O. Missed first dose of the COVID-19 vaccine: a
qualitative study on vaccine hesitancy among healthcare workers in Nigeria. 2021;7:65-76.
doi:10.18683/jccp.2021.1073
61.
Iwuagwu AO, Rayner D, Ngwu CN, Kalu ME. Why I Have Not Taken the COVID-19
Vaccine" a Descriptive Qualitative Study of Older Adults’ Perceived Views of COVID-19
Vaccine Uptake in Nigeria. J Popul Ageing. Published online February 2, 2023:1-21.
doi:10.1007/s12062-023-09410-z
62.
Ogueji I, Okoloba M. Underlying factors in the willingness to receive and barriers to
receiving the COVID-19 vaccine among residents in the UK and Nigeria: a qualitative study.
Current Psychology. 2022;42:3. doi:10.1007/s12144-021-02498-6
63.
Zwawua O, Kor E. Factors Associated with COVID-19 Vaccine Hesitancy among a
Rural Sample in Benue State, Nigeria: A Qualitative Study. Nigerian Journal of Health
Promotion. 2023;15(1):59-68.
9364.
Jiao L, Wachinger J, Dasch S, Bärnighausen T, McMahon SA, Chen S. Calculation,
knowledge, and identity: Dimensions of trust when making COVID-19 vaccination choices in
China. SSM Qual Res Health. 2023;4:100288. doi:10.1016/j.ssmqr.2023.100288
65.
Gauld N, Martin SNP, Sinclair OTR, Dumble F, Petousis-Harris H, Grant CC. Mapping
the maternal vaccination journey and influencing factors for Māori women in Aotearoa New
Zealand: a qualitative study. J Prim Health Care. 2022;14(4):352-362. doi:10.1071/HC21166
66.
Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative
Research. Aldine.; 1967. Cited in Creswell JW. Qualitative Inquiry and Research Design:
Choosing Among Five Approaches. 2nd ed. SAGE Publications; 2007
67.
Strauss AL, Corbin J. Basics of Qualitative Research: Grounded Theory Procedures
and Techniques. SAGE Publications; 1990. Cited in Creswell JW. Qualitative Inquiry and
Research Design: Choosing Among Five Approaches. 2nd ed. SAGE Publications; 2007
68.
Creswell JW. Qualitative Inquiry and Research Design: Choosing Among Five
Approaches. 2nd ed. SAGE Publications; 2007.
69.
Nigeria: number of internet users by state 2021. Statista.
https://www.statista.com/statistics/1334447/number-of-internet-users-in-nigeria-by-state/
70.
Weber M. Economy and Society: An Outline of Interpretive Sociology. University of
California Press; 1978.
71.
Authority, n. meanings, etymology and more | Oxford English Dictionary. In: Oxford
English Dictionary. Oxford University Press; 2023.
https://www.oed.com/search/advanced/Entries?q=authority&sortOption=Frequency
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊